• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » IMARC Research opens new office

IMARC Research opens new office

October 17, 2016
CenterWatch Staff

IMARC Research, a CRO based in Strongsville, Ohio, recently expanded its footprint in the medical device market by opening a new office in the Minneapolis area.

The new office, located at 12800 Whitewater Drive, Suite 100, in Minnetonka, Minnesota, underscores IMARC's continued growth and commitment to ensuring compliance for medical device research.

"Minneapolis is a strong medical device market, so this new location will allow us to better serve our current clients and develop exciting new partnerships," IMARC CEO and President Sandra Maddock said. "We are eager to assist in advancing clinical research by bringing cost-effective monitoring, managing data safety monitoring boards and clinical events committees, auditing, training, project management and other services closer to home for researchers in this area."

IMARC Senior Clinical Research Specialist James Moat will manage the new location. Moat is a Certified Clinical Research Associate with more than 26 years of experience in medical device product development, having managed all phases of clinical study—from pre-market strategy to post-market surveillance. His primary area of expertise is cardiology, but he also has extensive experience managing obesity, orthopedic and stroke projects.

IMARC currently has three employees in Minneapolis and plans to hire additional staff soon.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing